Mostrando 1 - 7 de 7
Operations
# Título Última modificação Estado Published status
1 Main adverse reactions motivating the substitution of Dolutegravir in Antiretroviral Therapy regimens in Brazil
Main adverse reactions motivating the substitution of Dolutegravir in Antiretroviral Therapy regimens in Brazil
 		31.07.2018 - 10:39 Yes
2 How it was possible to offer Integrase Inhibitor as first line ART while maintaining the sustainability of the Brazilian policy of universal access to drugs
How it was possible to offer Integrase Inhibitor as first line ART while maintaining the sustainability of the Brazilian policy of universal access to drugs
 		31.07.2018 - 10:36 Yes
3 Virological monitoring of the switch from RAL-containing to DTG-containing regimens in Brazil: data from a real-world cohort
Virological monitoring of the switch from RAL-containing to DTG-containing regimens in Brazil: data from a real-world cohort
 		31.07.2018 - 10:37 Yes
4 User profiles, regimen choices and types of exposure in HIV post-exposure prophylaxis before and after after the implementation of guidelines in Brazil
User profiles, regimen choices and types of exposure in HIV post-exposure prophylaxis before and after after the implementation of guidelines in Brazil
 		26.07.2018 - 17:53 Yes
5 Factors associated with adherence to antiretroviral therapy in Brazil in 2017
Factors associated with adherence to antiretroviral therapy in Brazil in 2017
 		26.07.2018 - 17:53 Yes
6 Clinical monitoring system for people living with HIV (SIMC) and continuum care improvement in Brazilian Brazil
Clinical monitoring system for people living with HIV (SIMC) and continuum care improvement in Brazilian Brazil
 		26.07.2018 - 17:53 Yes
7 Brazilian e-health strategy for expanding, strengthening and monitoring ART adherence
Brazilian e-health strategy for expanding, strengthening and monitoring ART adherence
 		26.07.2018 - 17:53 Yes